Stryker

YTD

ALL

Trade Stryker 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About SYK

Stryker Corp. is a medical technology company, which engages in the provision of products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments.

CEO

Kevin A. Lobo

CEOKevin A. Lobo

Employees

56,000

Employees56,000

Headquarters

Portage, Michigan

HeadquartersPortage, Michigan

Founded

1941

Founded1941

Employees

56,000

Employees56,000

SYK Key Statistics

Market cap

105.71B

Market cap105.71B

Price-Earnings ratio

28.88

Price-Earnings ratio28.88

Dividend yield

1.25%

Dividend yield1.25%

Average volume

2.83M

Average volume2.83M

High today

$279.50

High today$279.50

Low today

$273.05

Low today$273.05

Open price

$276.26

Open price$276.26

Volume

2.93M

Volume2.93M

52 Week high

$392.55

52 Week high$392.55

52 Week low

$267.00

52 Week low$267.00

Stock Snapshot

As of today, Stryker(SYK) shares are valued at $278.96. The company's market cap stands at 105.71B, with a P/E ratio of 28.88 and a dividend yield of 1.25%.

On 2026-09-30, Stryker(SYK) stock moved within a range of $273.05 to $279.50. With shares now at $278.96, the stock is trading +2.2% above its intraday low and -0.2% below the session's peak.

Trading activity shows a volume of 2.93M, compared to an average daily volume of 2.83M.

Over the past 52 weeks, Stryker(SYK) stock has traded between a high of $392.55 and a low of $267.00.

SYK News

TipRanks 14h

Stryker price target lowered to $330 from $360 at Stifel

Stifel lowered the firm’s price target on Stryker (SYK) to $330 from $360 and keeps a Buy rating on the shares. Management highlighted two incremental, unantici...

Investing.com 1d

Stifel cuts Stryker stock price target on revenue pressures - Investing.com

...

Simply Wall St 3d

Why Stryker Is Back In The Spotlight

Stryker (SYK) is back in the spotlight after unveiling new Foot & Ankle technologies at the 2026 American Orthopaedic Foot & Ankle Society meeting in Seattle, i...

Analyst ratings

83%

of 30 ratings

Buy

83.3%

Hold

16.7%

Sell

More SYK News

Simply Wall St 5d

How Investors Are Reacting To Stryker Ankle Surgery Planning Launch

Stryker recently showcased new Foot & Ankle technologies at the 2026 AOFAS meeting, including Prophecy Surgical Planning for the Incompass Total Ankle System an...

People also own

Based on the portfolios of people who own SYK. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.